Vulnerable shields — the cell walls of bacteria and fungi

  • T. J. Franklin
  • G. A. Snow


In the search for differences between microbial pathogens and animal cells that could provide the basis for selective antimicrobial attack, one evident distinction lies in their general structure. The animal cell is relatively large and has a complex organization; its biochemical processes are compartmentalized and different functions are served by the nucleus with its surrounding membrane, by the mitochondria and by various other organelles. The cytoplasmic membrane is thin and lacks rigidity. The cell exists in an environment controlled in temperature in mammals and birds and also in osmolarity. It is constantly supplied with nutrients from the extracellular fluid. Bacteria and fungi live in variable and often hostile environments and they must be able to withstand considerable changes in external osmolarity. Some micro-organisms have relatively high concentrations of low molecular weight solutes in their cytoplasm. Such cells suspended in water or in dilute solutions develop a high internal osmotic pressure. This would inevitably disrupt the cytoplasmic membrane unless it were provided with a tough, elastic outer coat. This coat is the cell wall, a characteristic of bacteria and fungi which is entirely lacking in animal cells. It has a protective function but at the same time it is vulnerable to attack, and a number of antibacterial and antifungal drugs owe their action to their ability to disturb the processes by which the walls are synthesized. Since there is no parallel biosynthetic mechanism in animal cells, substances affecting this process may be highly selective in their antimicrobial action.


Teichoic Acid Glycan Chain Muramic Acid Peptidoglycan Synthesis Peptidoglycan Biosynthesis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further reading

  1. Brennan, P.J. (1995). The envelope of mycobacteria. Ann. Rev. Biochem. 64, 29–63.PubMedCrossRefGoogle Scholar
  2. Debono, M. and Gordee, R.S. (1994). Antibiotics that inhibit fungal cell wall development. Ann. Rev. Microbiol. 48, 471–97.CrossRefGoogle Scholar
  3. Doyle, R.J. and Marquis, R.E. (1994). Elastic, flexible peptidoglycan and bacterial cell wall properties. Trends Microbiol. 2, 57–60.PubMedCrossRefGoogle Scholar
  4. Georgopapadakou, N.H. and Tkacz, J.S. (1995). The fungal cell wall as a drug target. Trends Microbiol. 3, 98.PubMedCrossRefGoogle Scholar
  5. Ghuysen, J.-M. (1991). Serine 3-lactamases and penicillin-binding proteins. Ann. Rev. Microbiol. 45, 37–67.CrossRefGoogle Scholar
  6. Ghuysen, J.-M. et al. (1996). Penicillin and beyond: evolution, protein fold, multimodular polypeptides and multiprotein complexes. Microb. Drug Resist. 2, 163–75.PubMedCrossRefGoogle Scholar
  7. Hancock, R.E. (1997). The bacterial outer membrane as a drug permeability barrier. Trends Microbiol. 5, 3742.CrossRefGoogle Scholar
  8. Johnsson, K. and Schulz, P.G. (1994). Mechanistic studies of the oxidation of isoniazid by the catalase-peroxidase from Mycobacterium tuberculosis. J. Am. Chem. Soc. 116, 7425–6.CrossRefGoogle Scholar
  9. Kurtz, M.B. and Douglas, C.M. (1997). Lipopeptide inhibitors of fungal glucan synthase. J. Med. Vet. Mycol. 35, 79.PubMedCrossRefGoogle Scholar
  10. Prescott, L.M., Harley, J.P. and Klein, D.A. (1996). Microbiology, Wm. C. Brown, Dubuque IA.Google Scholar
  11. Schäffer, L.M., Schneider, T.R and Sheldrick G.M. (1996). Crystal structure of vancomycin. Structure 4, 1509–15.CrossRefGoogle Scholar
  12. Skarzynski, T. et al. (1996). Structure of UDP-N-acetyl glucosamine enol pyruvyl transferase: an enzyme essential for the synthesis of bacterial peptidoglycan, complexed with substrate UDP-N-acetyl glucosamine and the drug fosfomycin. Structure 4, 1465–74.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1998

Authors and Affiliations

  • T. J. Franklin
    • 1
  • G. A. Snow
    • 1
  1. 1.Zeneca PharmaceuticalsMacclesfield, CheshireUK

Personalised recommendations